Sponsor
Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial steps after inspection
Posted
Sun Pharmaceutical Industries faces scrutiny. The USFDA issued a Form 483. This follows an inspection of its Halol manufacturing plant in Gujarat. The inspection occurred between June 2 and June 13, 2025. Eight observations were noted regarding Good Manufacturing Practices. Sun Pharma is expected to respond. They will submit a remediation plan to address the concerns.
Zoeken
Categorieën
- National
- International
- Business
- Technology
- Health
- Onderwijs
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
11 sixes! DC flop Jake Fraser-McGurk lights up cricket in USA - Watch
Jake Fraser-McGurk's explosive 88 off 38 balls propelled San Francisco Unicorns to a formidable...
Mohanlal jokingly calls Mohan Babu a short-tempered person
Mohanlal and Vishnu Manchu were recently seen attending a promotional event for their upcoming...
Cooperative fraud case filed against Rabi Lamichhane and 28 others in Parsa
KATHMANDU: A case has been filed at the Parsa District Court against former Home Minister and...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Dutch
